CJJD
Income statement / Annual
Last year (2024), China Jo-Jo Drugstores, Inc.'s total revenue was $154.54 M,
an increase of 3.85% from the previous year.
In 2024, China Jo-Jo Drugstores, Inc.'s net income was -$4.23 M.
See China Jo-Jo Drugstores, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
03/31/2024 |
03/31/2023 |
03/31/2022 |
03/31/2021 |
03/31/2020 |
03/31/2019 |
03/31/2018 |
03/31/2017 |
03/31/2016 |
03/31/2015 |
| Operating Revenue |
$154.54 M |
$148.81 M |
$164.39 M |
$133.13 M |
$117.33 M |
$107.55 M |
$96.11 M |
$81.50 M |
$89.07 M |
$76.90 M |
| Cost of Revenue |
$123.43 M
|
$114.53 M
|
$127.87 M
|
$103.89 M
|
$91.80 M
|
$82.44 M
|
$75.99 M
|
$64.87 M
|
$71.55 M
|
$64.46 M
|
| Gross Profit |
$31.11 M
|
$34.28 M
|
$36.52 M
|
$29.24 M
|
$25.53 M
|
$25.11 M
|
$20.13 M
|
$16.63 M
|
$17.51 M
|
$12.44 M
|
| Gross Profit Ratio |
0.2
|
0.23
|
0.22
|
0.22
|
0.22
|
0.23
|
0.21
|
0.2
|
0.2
|
0.16
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$7.26 M
|
$15.67 M
|
$8.19 M
|
$10.90 M
|
$8.11 M
|
$1.72 M
|
$17.82 M
|
$7.68 M
|
$5.18 M
|
$313.39 K
|
| Selling & Marketing Expenses |
$27.39 M
|
$29.18 M
|
$30.88 M
|
$26.95 M
|
$23.79 M
|
$24.27 M
|
$18.74 M
|
$12.92 M
|
$12.36 M
|
$10.42 M
|
| Selling, General & Administrative Expenses |
$34.64 M
|
$44.85 M
|
$39.06 M
|
$37.85 M
|
$31.90 M
|
$25.98 M
|
$36.56 M
|
$20.61 M
|
$17.54 M
|
$10.73 M
|
| Other Expenses |
$0.00
|
$1.68 M
|
$455.55 K
|
$176.52 K
|
-$204.06 K
|
-$93.31 K
|
$201.10 K
|
$19.89 K
|
-$43.54 K
|
$295.02 K
|
| Operating Expenses |
$34.64 M
|
$44.85 M
|
$39.06 M
|
$37.85 M
|
$31.90 M
|
$25.98 M
|
$36.56 M
|
$20.61 M
|
$17.54 M
|
$10.73 M
|
| Cost And Expenses |
$158.08 M
|
$159.38 M
|
$166.94 M
|
$141.74 M
|
$123.70 M
|
$108.43 M
|
$112.55 M
|
$85.48 M
|
$89.09 M
|
$75.19 M
|
| Interest Income |
$516.64 K
|
$883.91 K
|
$401.92 K
|
$707.88 K
|
$1.06 M
|
$112.89 K
|
$478.98 K
|
$379.79 K
|
$299.51 K
|
$0.00
|
| Interest Expense |
$13.60 K
|
$65.85 K
|
$262.22 K
|
$455.19 K
|
$698.52 K
|
$241.84 K
|
$1.23 M
|
$1.35 K
|
$155.58 K
|
$1.88 M
|
| Depreciation & Amortization |
$5.38 M
|
$718.00 K
|
$1.26 M
|
$1.81 M
|
$2.08 M
|
$1.45 M
|
$1.38 M
|
$1.32 M
|
$1.46 M
|
$2.82 M
|
| EBITDA |
$1.23 M |
-$19.96 M |
-$579.93 K |
-$6.08 M |
-$3.66 M |
$266.56 K |
-$15.05 M |
-$4.24 M |
$2.00 M |
$4.53 M |
| EBITDA Ratio |
0.01
|
-0.13
|
-0
|
-0.05
|
-0.03
|
0
|
-0.16
|
-0.05
|
0.02
|
0.06
|
| Operating Income Ratio |
-0.02
|
-0.07
|
-0.02
|
-0.06
|
-0.05
|
-0.01
|
-0.17
|
-0.05
|
-0
|
0.02
|
| Total Other Income/Expenses Net |
-$636.82 K
|
$181.15 K
|
$446.46 K
|
$264.79 K
|
-$65.87 K
|
-$306.88 K
|
-$545.69 K
|
-$1.58 M
|
$568.66 K
|
-$795.16 K
|
| Income Before Tax |
-$4.17 M
|
-$20.74 M
|
-$2.10 M
|
-$8.34 M
|
-$6.44 M
|
-$1.18 M
|
-$16.98 M
|
-$5.56 M
|
$543.90 K
|
$913.03 K
|
| Income Before Tax Ratio |
-0.03
|
-0.14
|
-0.01
|
-0.06
|
-0.05
|
-0.01
|
-0.18
|
-0.07
|
0.01
|
0.01
|
| Income Tax Expense |
$62.86 K
|
$394.54 K
|
$1.10 M
|
$31.64 K
|
$16.26 K
|
$134.76 K
|
$76.26 K
|
$84.39 K
|
$96.74 K
|
$57.40 K
|
| Net Income |
-$4.23 M
|
-$21.14 M
|
-$3.20 M
|
-$8.38 M
|
-$6.46 M
|
-$1.32 M
|
-$17.06 M
|
-$5.64 M
|
$447.16 K
|
$856.56 K
|
| Net Income Ratio |
-0.03
|
-0.14
|
-0.02
|
-0.06
|
-0.06
|
-0.01
|
-0.18
|
-0.07
|
0.01
|
0.01
|
| EPS |
-2.93 |
-41.46 |
-220.62 |
-49.29 |
-47.23 |
-0.55 |
-8.16 |
-3.36 |
0.36 |
0.72 |
| EPS Diluted |
-2.93 |
-41.46 |
-220.62 |
-49.29 |
-47.23 |
-0.55 |
-8.11 |
-3.32 |
0.36 |
0.72 |
| Weighted Average Shares Out |
$1.44 M
|
$509.83 K
|
$14.50 K
|
$169.92 K
|
$136.74 K
|
$2.41 M
|
$2.09 M
|
$1.68 M
|
$1.34 M
|
$1.25 M
|
| Weighted Average Shares Out Diluted |
$1.44 M
|
$509.83 K
|
$14.50 K
|
$169.92 K
|
$136.74 K
|
$2.41 M
|
$2.10 M
|
$1.70 M
|
$1.35 M
|
$1.26 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
